TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Review

TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy

Online download statistics by month:

Online download statistics by month: April 2022 to March 2024

	Abstract	Full	Pdf
Apr 2022	1345	1428	623
May 2022	1159	1209	437
Jun 2022	1166	1199	346
Jul 2022	629	662	200
Aug 2022	689	702	174
Sep 2022	597	611	165
Oct 2022	630	653	224
Nov 2022	650	658	263
Dec 2022	549	558	186
Jan 2023	521	537	179
Feb 2023	568	576	188
Mar 2023	510	521	242
Apr 2023	704	711	232
May 2023	547	553	176
Jun 2023	478	484	194
Jul 2023	324	337	151
Aug 2023	328	336	136
Sep 2023	393	405	127
Oct 2023	496	503	158
Nov 2023	388	395	155
Dec 2023	452	461	164
Jan 2024	296	301	177
Feb 2024	371	379	176
Mar 2024	598	603	316
Total	14388	14782	5389